Prognostic implications of mono-hit and multi-hit TP53 alterations in patients with acute myeloid leukemia and higher risk myelodysplastic syndromes treated with azacitidine-based therapy Research Letter

  

Authors:	Zeidan, A. M.; Bewersdorf, J. P.; Hasle, V.; Shallis, R. M.; Thompson, E.; de Menezes, D. L.; Rose, S.; Boss, I.; Halene, S.; Haferlach, T.; Fox, B.
Title:	Prognostic implications of mono-hit and multi-hit TP53 alterations in patients with acute myeloid leukemia and higher risk myelodysplastic syndromes treated with azacitidine-based therapy
Keywords:	genetics; leukemia, myeloid, acute; antimetabolites, antineoplastic; protein p53; myelodysplastic syndrome; tumor suppressor protein p53; antineoplastic antimetabolite; tp53 protein, human; azacitidine; myelodysplastic syndromes; acute myeloid leukemia; humans; prognosis; human
Journal Title:	Leukemia
Volume:	37
Issue:	1
ISSN:	0887-6924
Publisher:	Nature Publishing Group
Date Published:	2023-01-01
Start Page:	240
End Page:	243
Language:	English
DOI:	10.1038/s41375-022-01766-z
PUBMED:	36437356
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85142762049&doi=10.1038%2fs41375-022-01766-z&partnerID=40&md5=ef8f8d9e2081eff7c1e45fdab6f775f6
Notes:	Article -- Export Date: 1 March 2023 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/203449